The multifaceted role of neurofilament light chain protein in non-primary neurological diseases
Brain · 2023
DOI: 10.1093/brain/awac328 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain, 2023. Verfasst von Samir Abu-Rumeileh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Martin-Luther-University of Halle-Wittenberg, Halle (Saale), Germany. Hauptthemen laut MEDLINE: COVID-19, Nervous System Diseases. Die Arbeit wurde bisher 122-mal zitiert (Crossref) und nennt 195 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The advancing validation and exploitation of CSF and blood neurofilament light chain protein as a biomarker of neuroaxonal damage has deeply changed the current diagnostic and prognostic approach to neurological diseases. Further, recent studies have provided evidence of potential new applications of this biomarker also in non-primary neurological diseases. In the present review we summarize the state of the art, future perspectives, but also limitations, of neurofilament light chain protein as a CSF and blood biomarker in several medical fields, including intensive care medicine, surgery, internal medicine and psychiatry. In particular, neurofilament light chain protein is associated with the degree of neurological impairment and outcome in patients admitted to intensive care units or in the perioperative phase and it seems to be highly interconnected with cardiovascular risk factors. Beyond that, interesting diagnostic and prognostic insights have been provided by the investigation of neurofilament light chain protein in psychiatric disorders as well as in the current coronavirus disease-19 pandemic and in normal ageing. Altogether, current data outline a multifaceted applicability of CSF and blood neurofilament light chain protein ranging from the critical clinical setting to the development of precision medicine models suggesting a strict interplay between the nervous system pathophysiology and the health-illness continuum.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Martin-Luther-University of Halle-Wittenberg, Halle (Saale), Germany.
- Department of Neurology, University of California San Francisco (UCSF), San Francisco, USA.
- Department of Neurology, Ulm University Hospital, Ulm, Germany.
- Department of Neuroscience, Neurology Unit-S. Maria delle Croci Hospital of Ravenna, AUSL Romagna, Ravenna, Italy.
- Department of Stroke and Neuroscience, Charing Cross Hospital, Imperial College London, NHS Healthcare Trust, London, UK.
- Department of Brain Sciences, Imperial College London, London, UK.
ORCID-Profile: Samir Abu-Rumeileh, Ahmed Abdelhak, Jens Kuhle
Zitieren
APA
Abu-Rumeileh, S., Abdelhak, A., Foschi, M., D'Anna, L., Russo, M., Steinacker, P., Kuhle, J., Tumani, H., Blennow, K., & Otto, M. (2023). The multifaceted role of neurofilament light chain protein in non-primary neurological diseases. Brain. https://doi.org/10.1093/brain/awac328
Vancouver
Abu-Rumeileh S, Abdelhak A, Foschi M, D'Anna L, Russo M, Steinacker P, et al. The multifaceted role of neurofilament light chain protein in non-primary neurological diseases. Brain. 2023. doi:10.1093/brain/awac328
BibTeX
@article{AbuRumeileh2023,
author = {Abu-Rumeileh, Samir and Abdelhak, Ahmed and Foschi, Matteo and D'Anna, Lucio and Russo, Michele and Steinacker, Petra and Kuhle, Jens and Tumani, Hayrettin and Blennow, Kaj and Otto, Markus},
title = {The multifaceted role of neurofilament light chain protein in non-primary neurological diseases},
journal = {Brain},
year = {2023},
doi = {10.1093/brain/awac328}
}
EUVIMED